Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Erasca will join Morgan Stanley’s 2026 Global Healthcare Conference, offering a webcast fireside chat and a 30-day replay for investors.

Rhea-AI Summary

Erasca (ERAS) will present at the Morgan Stanley 24th Annual Global Healthcare Conference at the New York Marriott Marquis in New York, NY. Management is scheduled for a fireside chat on Tuesday, September 15, 2026, at 1:05 p.m. Eastern Time and will hold one-on-one investor meetings. A live audio webcast and a 30-day archived replay will be accessible at Erasca.com/events.

Key Terms

ras/mapk pathway

1 terms

ras/mapk pathway technical

"focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers"

A cellular signaling route that acts like a chain of command inside cells to tell them when to grow, divide, or die; when parts of this RAS/MAPK pathway are stuck “on,” it can drive uncontrolled cell growth that leads to cancer. Investors care because drugs, tests, or diagnostics that target or measure this pathway can become valuable products, affect drug approval chances, and change a company’s revenue or risk profile much like fixing a critical production line in a factory.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference being held at the New York Marriott Marquis in New York, NY. Management will participate in a fireside chat on Tuesday, September 15, 2026, at 1:05 pm Eastern Time and will also participate in one-on-one investor meetings.

A live audio webcast of the event will be available online at Erasca.com/events. An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.

About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of patients with cancer. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com 

Media Contact:
Michael Fitzhugh
LifeSci Communications
mfitzhugh@lifescicomms.com 

FAQ

When and where will Erasca’s fireside chat at the Morgan Stanley conference take place?

The fireside chat will take place on Tuesday, September 15, 2026, at 1:05 p.m. Eastern Time during the Morgan Stanley 24th Annual Global Healthcare Conference at the New York Marriott Marquis in New York, NY.

How can investors access the live webcast of Erasca’s presentation?

Investors can access the live audio webcast online at Erasca.com/events at the time of the fireside chat.

Will a replay of Erasca’s conference presentation be available?

Yes. An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.

Will Erasca hold investor meetings during the Morgan Stanley conference?

Yes. Management will also participate in one-on-one investor meetings during the conference.